SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-19-063377
Filing Date
2019-03-05
Accepted
2019-03-05 09:58:33
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d680204dsc14d9.htm SC 14D9 421045
2 EX-99.(E)(15) d680204dex99e15.htm EX-99.(E)(15) 10582
3 EX-99.(E)(16) d680204dex99e16.htm EX-99.(E)(16) 9019
4 EX-99.(E)(17) d680204dex99e17.htm EX-99.(E)(17) 9153
5 GRAPHIC g680204dsp01.jpg GRAPHIC 6361
  Complete submission text file 0001193125-19-063377.txt   460687
Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Filed by) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-88256 | Film No.: 19656910
SIC: 2834 Pharmaceutical Preparations